Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis
L D
LD
British Biotech Pharmaceuticals Limited, Oxford, United Kingdom.
D000208:Acute Disease; D000818:Animals; D007930:Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors; D051381:Rats; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled
C094498:BB 882; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; D007930:Leucine